Works matching IS 00207136 AND DT 2022 AND VI 150 AND IP 7


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 7, p. 1141, doi. 10.1002/ijc.33865
    By:
    • Liu, Yi;
    • Wang, Sanmei;
    • Schubert, Maria‐Luisa;
    • Lauk, Annika;
    • Yao, Hao;
    • Blank, Maximilian Felix;
    • Cui, Chunhong;
    • Janssen, Maike;
    • Schmidt, Christina;
    • Göllner, Stefanie;
    • Kleist, Christian;
    • Zhou, Fengbiao;
    • Rahfeld, Jens‐Ulrich;
    • Sauer, Tim;
    • Schmitt, Michael;
    • Müller‐Tidow, Carsten
    Publication type:
    Article
    14
    15

    Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 7, p. 1166, doi. 10.1002/ijc.33834
    By:
    • Conteduca, Vincenza;
    • Scarpi, Emanuela;
    • Wetterskog, Daniel;
    • Brighi, Nicole;
    • Ferroni, Fabio;
    • Rossi, Alice;
    • Romanel, Alessandro;
    • Gurioli, Giorgia;
    • Bleve, Sara;
    • Gianni, Caterina;
    • Schepisi, Giuseppe;
    • Lolli, Cristian;
    • Cortesi, Pietro;
    • Matteucci, Federica;
    • Barone, Domenico;
    • Paganelli, Giovanni;
    • Demichelis, Francesca;
    • Beltran, Himisha;
    • Attard, Gerhardt;
    • De Giorgi, Ugo
    Publication type:
    Article
    16

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 7, p. 1069, doi. 10.1002/ijc.33636
    Publication type:
    Article
    17

    Issue Information.

    Published in:
    International Journal of Cancer, 2022, v. 150, n. 7, p. 1215, doi. 10.1002/ijc.33635
    Publication type:
    Article